Estrogen and androgen levels in women treated with radiation for cervical cancer-possible influence on breast cancer risk

Nancy L. Eby, John D. Boice, Ellen B Gold, Robert N. Hoover, D. Lynn Loriaux

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In 1984-1985, estrogen and androgen levels in blood sera were measured in 320 women who had been treated for cervical cancer in the earty 1960s. Study subjects were from US clinics in Baltimore, Maryland; Boston and Norfolk, Massachusetts; Buffalo, New York; Houston, Texas; and San Juan, Puerto Rico. These clinics had participated in a larger international follow-up study of cervical cancer in which a 20-30% reduction In breast cancer risk was linked to prior pelvic irradiation, even when treatment occurred after menopause. Overall, the 203 irradiated and 117 nonirradlated women had similar mean levels of estradiol, estrone, androstenedione, and testosterone. However, there appeared to be negative, albeit inconsistent, trends for androstenedione, testosterone, and estrone, suggesting that the irradiated women had lower levels of these hormones when compared with the nonirradlated women. These differences did not reach the level of statistical significance. While chance could partially explain these findings, it is plausible that the frequently observed protective association of breast cancer with pelvic irradiation could be due in part to a decrease in steroid hormones that is secondary, perhaps, to adrenal irradiation.

Original languageEnglish (US)
Pages (from-to)527-532
Number of pages6
JournalAmerican Journal of Epidemiology
Volume129
Issue number3
StatePublished - Mar 1989
Externally publishedYes

Fingerprint

Uterine Cervical Neoplasms
Androgens
Estrogens
Radiation
Breast Neoplasms
Androstenedione
Estrone
Testosterone
Hormones
Puerto Rico
Baltimore
Buffaloes
Menopause
Estradiol
Steroids
Serum
Therapeutics

Keywords

  • Androgens
  • Breast neoplasms
  • Estrogens
  • Ovariectomy
  • Radiotherapy

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Epidemiology

Cite this

Estrogen and androgen levels in women treated with radiation for cervical cancer-possible influence on breast cancer risk. / Eby, Nancy L.; Boice, John D.; Gold, Ellen B; Hoover, Robert N.; Loriaux, D. Lynn.

In: American Journal of Epidemiology, Vol. 129, No. 3, 03.1989, p. 527-532.

Research output: Contribution to journalArticle

Eby, Nancy L. ; Boice, John D. ; Gold, Ellen B ; Hoover, Robert N. ; Loriaux, D. Lynn. / Estrogen and androgen levels in women treated with radiation for cervical cancer-possible influence on breast cancer risk. In: American Journal of Epidemiology. 1989 ; Vol. 129, No. 3. pp. 527-532.
@article{9ae7437de7154ef0986efceef4baad84,
title = "Estrogen and androgen levels in women treated with radiation for cervical cancer-possible influence on breast cancer risk",
abstract = "In 1984-1985, estrogen and androgen levels in blood sera were measured in 320 women who had been treated for cervical cancer in the earty 1960s. Study subjects were from US clinics in Baltimore, Maryland; Boston and Norfolk, Massachusetts; Buffalo, New York; Houston, Texas; and San Juan, Puerto Rico. These clinics had participated in a larger international follow-up study of cervical cancer in which a 20-30{\%} reduction In breast cancer risk was linked to prior pelvic irradiation, even when treatment occurred after menopause. Overall, the 203 irradiated and 117 nonirradlated women had similar mean levels of estradiol, estrone, androstenedione, and testosterone. However, there appeared to be negative, albeit inconsistent, trends for androstenedione, testosterone, and estrone, suggesting that the irradiated women had lower levels of these hormones when compared with the nonirradlated women. These differences did not reach the level of statistical significance. While chance could partially explain these findings, it is plausible that the frequently observed protective association of breast cancer with pelvic irradiation could be due in part to a decrease in steroid hormones that is secondary, perhaps, to adrenal irradiation.",
keywords = "Androgens, Breast neoplasms, Estrogens, Ovariectomy, Radiotherapy",
author = "Eby, {Nancy L.} and Boice, {John D.} and Gold, {Ellen B} and Hoover, {Robert N.} and Loriaux, {D. Lynn}",
year = "1989",
month = "3",
language = "English (US)",
volume = "129",
pages = "527--532",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Estrogen and androgen levels in women treated with radiation for cervical cancer-possible influence on breast cancer risk

AU - Eby, Nancy L.

AU - Boice, John D.

AU - Gold, Ellen B

AU - Hoover, Robert N.

AU - Loriaux, D. Lynn

PY - 1989/3

Y1 - 1989/3

N2 - In 1984-1985, estrogen and androgen levels in blood sera were measured in 320 women who had been treated for cervical cancer in the earty 1960s. Study subjects were from US clinics in Baltimore, Maryland; Boston and Norfolk, Massachusetts; Buffalo, New York; Houston, Texas; and San Juan, Puerto Rico. These clinics had participated in a larger international follow-up study of cervical cancer in which a 20-30% reduction In breast cancer risk was linked to prior pelvic irradiation, even when treatment occurred after menopause. Overall, the 203 irradiated and 117 nonirradlated women had similar mean levels of estradiol, estrone, androstenedione, and testosterone. However, there appeared to be negative, albeit inconsistent, trends for androstenedione, testosterone, and estrone, suggesting that the irradiated women had lower levels of these hormones when compared with the nonirradlated women. These differences did not reach the level of statistical significance. While chance could partially explain these findings, it is plausible that the frequently observed protective association of breast cancer with pelvic irradiation could be due in part to a decrease in steroid hormones that is secondary, perhaps, to adrenal irradiation.

AB - In 1984-1985, estrogen and androgen levels in blood sera were measured in 320 women who had been treated for cervical cancer in the earty 1960s. Study subjects were from US clinics in Baltimore, Maryland; Boston and Norfolk, Massachusetts; Buffalo, New York; Houston, Texas; and San Juan, Puerto Rico. These clinics had participated in a larger international follow-up study of cervical cancer in which a 20-30% reduction In breast cancer risk was linked to prior pelvic irradiation, even when treatment occurred after menopause. Overall, the 203 irradiated and 117 nonirradlated women had similar mean levels of estradiol, estrone, androstenedione, and testosterone. However, there appeared to be negative, albeit inconsistent, trends for androstenedione, testosterone, and estrone, suggesting that the irradiated women had lower levels of these hormones when compared with the nonirradlated women. These differences did not reach the level of statistical significance. While chance could partially explain these findings, it is plausible that the frequently observed protective association of breast cancer with pelvic irradiation could be due in part to a decrease in steroid hormones that is secondary, perhaps, to adrenal irradiation.

KW - Androgens

KW - Breast neoplasms

KW - Estrogens

KW - Ovariectomy

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0024602547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024602547&partnerID=8YFLogxK

M3 - Article

C2 - 2783832

AN - SCOPUS:0024602547

VL - 129

SP - 527

EP - 532

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 3

ER -